Hydroxychloroquine induces endothelium-dependent and endothelium-independent relaxation of rat aorta.
nitric oxide
Hydroxychloroquine
calcium channels
vasodilation
Journal
Turkish journal of medical sciences
ISSN: 1303-6165
Titre abrégé: Turk J Med Sci
Pays: Turkey
ID NLM: 9441758
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
30
04
2021
accepted:
22
01
2022
entrez:
3
11
2022
pubmed:
4
11
2022
medline:
8
11
2022
Statut:
ppublish
Résumé
Hydroxychloroquine (HCQ) is an antimalarial that is widely used in the management of rheumatoid arthritis and other autoimmune diseases. In this study, we aimed to examine the vascular effects of HCQ on rat aorta (RA). The RA rings were suspended in isolated organ baths and tension was recorded isometrically. HCQ-induced relaxations were tested in the presence of the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester (L-NAME, 100 mM); the cyclooxygenase enzyme inhibitor, indomethacin (10 mM); the calcium (Ca2+) ion channel blocker, nilvadipine (10 μM); and the K+ ion channel inhibitors, tetraethylammonium (1 mM), glibenclamide (10 mM), 4-aminopyridine (1 mM), and barium chloride (30 mM). The effect of HCQ on Ca2+ channels was examined using Ca2+-free Krebs solution, and adding calcium chloride (CaCl2 , 10-5- 10-2 M) cumulatively to baths incubated with HCQ. Removing the endothelium resulted in less relaxation of RA rings compared to endothelium-intact rings (p < 0.05). The effect of endothelium was supported by using L-NAME where HCQ produced-vasorelaxation was decreased (p < 0.05). The contraction of vascular rings was inhibited to a significant degree following the addition of CaCl2 , PE, or KCl on HCQ-incubated RA rings (p < 0.05). The incubation of the RA rings with the Ca2+ channel blocker, the K+ channel blockers, and the COX inhibitor, indomethacin did not significantly affect vascular relaxation induced by HCQ. HCQ produced relaxation of RA rings. The relaxation mechanism differs according to the concentration of HCQ. At con-centrations of 10-6 and 10-5 M, the relaxation is endothelium-dependent and mediated by NO. We strongly suggest that Ca2+ channel inhibition is involved at concentrations of 10-5 and 10-4 M, as well as NO.
Sections du résumé
BACKGROUND
BACKGROUND
Hydroxychloroquine (HCQ) is an antimalarial that is widely used in the management of rheumatoid arthritis and other autoimmune diseases. In this study, we aimed to examine the vascular effects of HCQ on rat aorta (RA).
METHODS
METHODS
The RA rings were suspended in isolated organ baths and tension was recorded isometrically. HCQ-induced relaxations were tested in the presence of the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester (L-NAME, 100 mM); the cyclooxygenase enzyme inhibitor, indomethacin (10 mM); the calcium (Ca2+) ion channel blocker, nilvadipine (10 μM); and the K+ ion channel inhibitors, tetraethylammonium (1 mM), glibenclamide (10 mM), 4-aminopyridine (1 mM), and barium chloride (30 mM). The effect of HCQ on Ca2+ channels was examined using Ca2+-free Krebs solution, and adding calcium chloride (CaCl2 , 10-5- 10-2 M) cumulatively to baths incubated with HCQ.
RESULTS
RESULTS
Removing the endothelium resulted in less relaxation of RA rings compared to endothelium-intact rings (p < 0.05). The effect of endothelium was supported by using L-NAME where HCQ produced-vasorelaxation was decreased (p < 0.05). The contraction of vascular rings was inhibited to a significant degree following the addition of CaCl2 , PE, or KCl on HCQ-incubated RA rings (p < 0.05). The incubation of the RA rings with the Ca2+ channel blocker, the K+ channel blockers, and the COX inhibitor, indomethacin did not significantly affect vascular relaxation induced by HCQ.
DISCUSSION
CONCLUSIONS
HCQ produced relaxation of RA rings. The relaxation mechanism differs according to the concentration of HCQ. At con-centrations of 10-6 and 10-5 M, the relaxation is endothelium-dependent and mediated by NO. We strongly suggest that Ca2+ channel inhibition is involved at concentrations of 10-5 and 10-4 M, as well as NO.
Identifiants
pubmed: 36326331
doi: 10.55730/1300-0144.5382
pmc: PMC10390209
doi:
Substances chimiques
NG-Nitroarginine Methyl Ester
V55S2QJN2X
Hydroxychloroquine
4QWG6N8QKH
Calcium Chloride
M4I0D6VV5M
Indomethacin
XXE1CET956
Vasodilator Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
848-857Références
Br J Pharmacol. 2017 Nov;174(22):4155-4172
pubmed: 28849593
J Smooth Muscle Res. 2003 Jun;39(3):31-7
pubmed: 14572170
J Cardiovasc Pharmacol. 1994;24 Suppl 2:S92-107
pubmed: 7898101
J Clin Invest. 1998 Aug 1;102(3):595-605
pubmed: 9691096
Clin Exp Pharmacol Physiol. 2014 Apr;41(4):301-8
pubmed: 24552423
Clin Rev Allergy Immunol. 2012 Apr;42(2):145-53
pubmed: 21221847
Cell Physiol Biochem. 2015;37(3):1168-77
pubmed: 26402856
Hypertension. 2014 Aug;64(2):330-7
pubmed: 24842914
Ann Rheum Dis. 2018 Jan;77(1):98-103
pubmed: 28970215
Eur J Clin Pharmacol. 1993;45(1):85-8
pubmed: 8405035
Lupus. 1996 Jun;5 Suppl 1:S2-3
pubmed: 8803902
Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):271-3
pubmed: 15228498
Ann Vasc Surg. 2019 Oct;60:397-406
pubmed: 31200052
Br J Pharmacol. 2020 Jan;177(2):314-327
pubmed: 31503328
J Pharmacol Sci. 2007 Jun;104(2):122-9
pubmed: 17538231
Nat Rev Rheumatol. 2012 Sep;8(9):522-33
pubmed: 22801982
Clin Pharmacol Ther. 1997 Jun;61(6):677-83
pubmed: 9209251
Fundam Clin Pharmacol. 2019 Oct;33(5):504-523
pubmed: 30851197
Nat Rev Rheumatol. 2020 Mar;16(3):155-166
pubmed: 32034323
Nature. 1983 Oct 13-19;305(5935):627-30
pubmed: 6621711
Hypertension. 2009 Mar;53(3):532-8
pubmed: 19188524
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):e108-e114
pubmed: 28835487
J Soc Gynecol Investig. 2006 May;13(4):312-5
pubmed: 16697949
J Cardiovasc Pharmacol. 2011 Feb;57(2):133-9
pubmed: 20881603
J Pharmacol Exp Ther. 2007 Mar;320(3):1204-8
pubmed: 17164473
PLoS Med. 2020 Sep 3;17(9):e1003252
pubmed: 32881895
Anesth Analg. 1993 Jan;76(1):24-32
pubmed: 8418736
Ann Rheum Dis. 2018 Oct;77(10):e65
pubmed: 29080860
PLoS One. 2015 Apr 08;10(4):e0123043
pubmed: 25853881
J Pharmacol Sci. 2020 Mar;142(3):101-108
pubmed: 31874782
Heart Rhythm. 2015 Oct;12(10):2186-94
pubmed: 26025323
J Cardiothorac Vasc Anesth. 2019 Aug;33(8):2183-2191
pubmed: 30683593
Basic Clin Pharmacol Toxicol. 2010 Dec;107(6):919-24
pubmed: 20560926